Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers

NCT00580203 | Completed

• 1 other identifier: 04-017
• Study Type: observational
• Target: 1,468
• Locations: 1 country
• Sites: 1

Brief Summary

This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.

Conditions

Head and Neck Cancers

Keywords

HEENT cancers; larynx; thyroid; sarcoma; specimen analysis

Outcome Measures

Primary Outcomes (1)

• Collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Specimens will be used to investigate growth, development, and transformation of normal and abnormal cells in the future.

  36 months

Study Arms (1)

1

Patients with head and neck cancers

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with head and neck diseases who have had tissue, serum, urine, or other specimens removed or collected for diagnostic or therapeutic purposes.

You may qualify if:

• Patients with head and neck diseases are eligible if they have had tissue, serum, urine, or other specimens removed or collected for diagnostic or therapeutic purposes.
• Patients will be entered onto this protocol without preference for any racial or ethnic group.
• Patients may have received prior chemotherapy, radiation, surgical therapy, immunotherapy, or differentiation therapy.
• The specimen collected must be large enough to allow conventional testing necessary for patient care, with the portion of the specimen reserved for research laboratory analysis excised from residual tissue that would otherwise have been discarded.

You may not qualify if:

• Patients not giving informed consent will be excluded.

Sponsors & Collaborators

• Memorial Sloan Kettering Cancer Center: lead
• American Cancer Society, Inc.: collaborator

Study Sites (1)

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

• Related Info

Biospecimen

Retention: SAMPLES WITH DNA

Tissue and peripheral blood

MeSH Terms

Conditions

Head and Neck Neoplasms; Laryngeal Diseases; Thyroid Diseases; Sarcoma

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases; Endocrine System Diseases; Neoplasms, Connective and Soft Tissue; Neoplasms by Histologic Type

Study Officials

• Bhuvanesh Singh, MD

  Memorial Sloan Kettering Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 19, 2007
• First Posted: December 24, 2007
• Study Start: February 1, 2004
• Primary Completion: November 12, 2024
• Study Completion: November 12, 2024
• Last Updated: November 15, 2024

Record last verified: 2024-11

Locations

US (1)